colorectal cancer News
Most Popular colorectal cancer Story
Matuzumab in doubt after trial failure
There's trouble at Merck Serono's program for Matuzumab, which is in development for colorectal cancer. Merck KGaA says it is "reconsidering" further development of the therapy after the... Read more...
Latest Headlines
- February 27, 2008
- August 29, 2007
- September 27, 2006
- May 9, 2006
- March 19, 2006
- March 1, 2006
- February 12, 2006
- December 14, 2005
- December 11, 2005
- September 22, 2005
- August 29, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
